CATALYST PHARMACEUTICALS, INC. (CPRX)
Current price: $31.49
These defaults work well for most companies. Only adjust them if you have a specific view on this business's risk profile or long-term growth prospects.
Graham Number
√(22.5 × EPS × Book Value per Share)
$17.16
46% downside
Earnings Power Value
Normalized after-tax earnings ÷ required return (zero-growth)
$11.15
65% downside
DCF Fair Value
Projected free cash flow discounted to present value + terminal value
$92.88
+195% upside
P/E Fair Value
Earnings per share × target P/E multiple
$25.20
20% downside
Valuation estimates are models, not investment advice. They are highly sensitive to the assumptions chosen and carry significant uncertainty. Past fundamentals do not guarantee future performance.